Berkshire Asset Management Llc/Pa
Source: SEC Form 13F · as of Mar 2026Berkshire Asset Management Llc/Pa holds 19 biotech & pharma companies tracked by BioSniper, totaling $239.6M in value as of Mar 2026 (SEC Form 13F).
Companies held
19
Total value held
$239.6M
| Company | Shares | Value |
|---|---|---|
| ABBVAbbVie Inc. | 380,870 | $82.8M |
| JNJJOHNSON & JOHNSON | 249,741 | $61.0M |
| BMYBRISTOL MYERS SQUIBB CO | 593,856 | $36.0M |
| ABTABBOTT LABORATORIES | 306,714 | $31.5M |
| AMGNAMGEN INC | 26,738 | $9.4M |
| MRKMerck & Co., Inc. | 35,024 | $4.2M |
| LLYELI LILLY & Co | 3,955 | $3.6M |
| PMPhilip Morris International Inc | 16,220 | $2.7M |
| PFEPFIZER INC | 94,145 | $2.6M |
| UNHUnitedHealth Group Incorporated Common Stock (DE) | 7,253 | $2.0M |
| VRTXVERTEX PHARMACEUTICALS INC / MA | 3,152 | $1.4M |
| DGXQuest Diagnostics Incorporated | 2,630 | $515K |
| GEHCGE HealthCare Technologies Inc. | 4,278 | $305K |
| VTRSViatris Inc | 21,867 | $295K |
| BIIBBIOGEN INC. | 1,534 | $281K |
| IONSIONIS PHARMACEUTICALS INC | 3,637 | $273K |
| ELVElevance Health Inc. | 911 | $267K |
| GILDGILEAD SCIENCES, INC. | 1,735 | $242K |
| ACOGAlpha Cognition Inc. | 19,824 | $109K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.